SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-059995
Filing Date
2018-10-02
Accepted
2018-10-02 16:16:00
Documents
1
Period of Report
2018-09-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a18-36234_18k.htm 8-K 31477
  Complete submission text file 0001104659-18-059995.txt   32811
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 181101443
SIC: 2834 Pharmaceutical Preparations